Industry news that matters to you.  Learn more

SAP Announces Strategic Alliances to Drive Forward Genomic Research

SAP AG recently announced a strategic collaboration with Stanford School of Medicine to research the contribution of genetics, environmental exposures, behavior and other factors to disease susceptibility using the power of the SAP HANA platform. The company also announced its participation in the Global Alliance for Genomics and Health, a council of industry leaders working toward accelerating worldwide efforts to responsibly share and analyze large amounts of genomic and clinical data.

IU, Paradigm Team Up to Test Genomic Sequencing for Women with Aggressive Form of Breast Cancer

Indiana University cancer researchers are testing whether therapy incorporating advanced genomic technology will provide better outcomes than current treatments for those with an aggressive form of breast cancer.

New Versions of JMP Life Sciences Solutions Fuel Discoveries in Clinical Trials, Genomics Research

Risk-based monitoring methods new in JMP® Clinical software from SAS limit costly on-site audits of source data during clinical trials while protecting study participants. JMP Genomics now offers enhanced capabilities for analyzing data related to agriculture, pharmacogenomics, biotechnology and more.

bioTheranostics Announces Contract with Three Rivers Provider Network

bioTheranostics, Inc., the leading genomic solutions provider for cancer diagnosis, recently announced a contract with Three Rivers Provider Network for coverage of the company’s testing services, including CancerTARGET ID for accurate diagnosis of metastatic cancer, and Breast Cancer Index, which predicts risk of recurrence of early stage, estrogen receptor-positive breast cancer.

Enzymatics Launches Archer Targeted Sequencing Technology to Dramatically Enhance Gene Mutation Identification and Discovery

Enzymatics, Inc., a leading producer of molecular biology reagents, kits, assays and software, recently unveiled Archer™ Targeted Sequencing technology, which dramatically enhances gene mutation identification and discovery with high sensitivity and reduced costs. The technology was announced during the Advances in Genome Biology & Technology (AGBT) conference, which is recognized throughout the sequencing community as a cornerstone for the discussion of genomics research.